A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MODAFINIL (200 MG/DAY) FOR METHAMPHETAMINE DEPENDENCE
Saved in:
SHEARER, J., ET AL., A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MODAFINIL (200 MG/DAY) FOR METHAMPHETAMINE DEPENDENCE. ADDICTION, Vol. 104, no. 2 (2009), p. 224-233.
Ref.
158694
Location:
SIIS R.696 Archivo
Palabras clave:
Anfetaminas, Ceguera, Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Tratamiento médico
Anfetaminas, Ceguera, Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Tratamiento médico
Similar Items: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MODAFINIL (200 MG/DAY) FOR METHAMPHETAMINE DEPENDENCE
- RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF MODAFINIL FOR THE TREATMENT OF METHAMPHETAMINE DEPENDECE
- EFFECTS OF ORAL METHAMPHETAMINE ON COCAINE USE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
- A double-blind, placebo-controlled trial of modafinil for cocaine dependence
- MODAFINIL AND COCAINE: A DOUBLE-BLIND, PLACEBO-CONTROLLED DRUG INTERACTION STUDY
- Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
- Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial